INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 449m ago
House PTR49m ago
SEC 13F48m ago
Robinhood Chain48m ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02FWFogarty Patrick W0B / 150S150 trades$600K
  3. 03SPSaba Capital Management, L.P.65B / 19S · 11 late84 trades$21.64M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SJSheena Jonathan0B / 45S45 trades$3.01M
  8. 08SISarowitz Steven I2B / 34S36 trades$22.46M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 179 insiders$893K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

72,558 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
27
FK
Fung Peter KDirector
CDIOCardio Diagnostics Holdings, Inc.
Grant or award
A$6,249
2,306 sh
Dec 31, 2025Jan 6, 2026
Page 1530 of 1814
← PrevNext →
traded Dec 31, 2025
+6d
SEC Form 4

Evidence

27
DC
Dameron CliftonSVP, GC & Corporate Secretary
WLFCWILLIS LEASE FINANCE CORP
Grant or award
A$600K
4,474 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

27
RK
Rasmussen KrisChief Technology Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$4.41M
119.4K sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

27
RK
Rasmussen KrisChief Technology Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$2.01M
53.3K sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

27
CJ
Carlson Anthony JDirector, President and CEO
ADARRAY DIGITAL INFRASTRUCTURE, INC.
Option exercise
M$271K
5,022 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

27
BS
Bulis Veronica SanchezVP, Corporate Controller
LYELLyell Immunopharma, Inc.
Open-market sale
SELL$30K
936 sh
Dec 30, 2025Jan 6, 2026
traded Dec 30, 2025
+7dSEC Form 4

Evidence

26
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$179K
4,432 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

26
TA
Thompson Travis AlvinCHIEF ACCOUNTING OFFICER
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$8,956
1,317 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

26
HF
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$19K
2,827 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

26
SA
Still AshleyDirector
DASHDoorDash, Inc.
Open-market sale · 10b5-1 plan
SELL$14K
63 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

24
JM
Johnson Gwendolyn MarySVP - Asset Management
EPREPR PROPERTIES
Gift
G—
7,997 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

24
RK
Rasmussen KrisChief Technology Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$332K
8,662 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

24
RK
Rasmussen KrisChief Technology Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$263K
7,017 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

24
OL
Obermaier Patricia LDirector
ASGNEverforth Inc
Grant or award
A$201K
4,500 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

24
RK
Rasmussen KrisChief Technology Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$267K
7,235 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

24
JM
Johnson Gwendolyn MarySVP - Asset Management
EPREPR PROPERTIES
Gift
G—
7,997 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

24
JJ
Johns JemmaEVP, CHRO
IRMIRON MOUNTAIN INC
Tax withholding
F$79K
944 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

23
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$16K
412 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

23
BC
Blevins ChristopherGeneral Counsel
SBDSSolo Brands, Inc.
Option exercise
M—
12 sh
Jan 1, 2026Jan 6, 2026
traded Jan 1, 2026
+5dSEC Form 4

Evidence

23
BF
Burton Paul FrederickDirector
CDIOCardio Diagnostics Holdings, Inc.
Grant or award
A$6,249
2,306 sh
Dec 31, 2025Jan 6, 2026
traded Dec 31, 2025
+6dSEC Form 4

Evidence

23
IS
Iyer SadasivamPresident
ASGNEverforth Inc
Grant or award
A$1000K
21.4K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

23
KR
Kelleher Eric RobertSee Remarks
OKTAOkta, Inc.
Open-market sale · 10b5-1 plan
SELL$144K
1,709 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

22
HF
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$15K
2,367 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

22
LM
Lin MarkEVP and CFO
SMTCSEMTECH CORP
Open-market sale · 10b5-1 plan
SELL$102K
1,333 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

22
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$5.66M
122.4K sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

22
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$2.07M
44.3K sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

22
TA
Thompson Travis AlvinCHIEF ACCOUNTING OFFICER
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$7,192
1,115 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

22
RV
Raghavan VaidyanathanChief Technology Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$153K
2,291 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

21
VS
Voskanian ShauntChief Revenue Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$73K
1,936 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

21
SB
Sachs Alan BruceDirector
QTRXQuanterix Corp
Grant or award
A—
23.4K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

21
TA
Thompson Travis AlvinCHIEF ACCOUNTING OFFICER
BCYCBICYCLE THERAPEUTICS PLC
Grant or award
A—
37.5K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

21
FT
Foote TimChief Financial Officer
BBBLACKBERRY Ltd
Option exercise
M—
34.9K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

21
MJ
Mason JenniferDirector
FUNSix Flags Entertainment Corporation/NEW
Grant or award
A—
13.0K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

21
MB
Mulligan BrendanGeneral Counsel and Secretary
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$162K
4,366 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

21
MB
Mulligan BrendanGeneral Counsel and Secretary
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$125K
3,344 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

21
VS
Voskanian ShauntChief Revenue Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$74K
1,997 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

21
RR
Rodriguez Joseph RyanChief Risk and Legal Officer
MVBFMVB FINANCIAL CORP
Option exercise
M—
5,112 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

21
DM
Durham MarkChief Accounting Officer
GTLSCHART INDUSTRIES INC
Grant or award
A—
1,050 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

21
KS
Kosaraju SheelaSVP and General Counsel
CIENCIENA CORP
Open-market sale · 10b5-1 plan
SELL$421K
1,748 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

21
HF
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
BCYCBICYCLE THERAPEUTICS PLC
Grant or award
A—
50.0K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence